Test Price
2,500 AED✅ Home Collection Available
Heparin Anti‑Xa Test in UAE | Therapeutic Drug Monitoring | DNA Labs UAE
Executive Summary & Core Metrics
Core Metrics for Informed Decisions
- Accuracy & Quality: ISO 15189 accredited chromogenic assay with rigorous internal quality controls.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by our General Practitioner.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Heparin Anti‑Xa assay is a chromogenic test that precisely quantifies unfractionated heparin levels in platelet‑poor plasma, essential for therapeutic drug monitoring in patients on heparin therapy. It ensures anticoagulation efficacy while preventing adverse bleeding or thrombotic events. This test is classified under our Therapeutic Drug Monitoring (TDM) panel and is reviewed by our clinical team upon result generation.
| Feature | Our Test (DHA‑Licensed) | Standard Alternative |
|---|---|---|
| Precision | Chromogenic assay, LC‑MS/MS validated; CV <2% | Basic chromogenic; inter‑lab variability >5% |
| Methodology | CLSI H47‑A2 compliant, anti‑Xa inhibition kinetics | Non‑standardized colorimetric |
| Speed | TAT 2–3 weeks, VIP courier dispatch | Often 4–6 weeks with uncertain logistics |
| Price | 2,500 AED | 1,800–2,200 AED |
| Insurance Support | Direct billing verification, real‑time pre‑approval | Manual reimbursement, long processing |
Physician Insight & Safety Protocols
Dr. Ajay Singh, General Practitioner (DHA Registration ID: 36234132), emphasizes: “I recognize that managing anticoagulation therapy can be complex. This test provides a reliable measure of heparin activity to guide dosing. However, results must always be interpreted in the context of your overall clinical status. Please consult your physician before making any changes to your treatment plan.”
Safety Advisory & Precautions
⚠️ Do not discontinue prescribed anticoagulation medication without consulting your doctor.
The Heparin Anti‑Xa test requires a fasting period of 8 hours. Please inform the collection team of all current medications, especially anticoagulants, antiplatelets, and NSAIDs.
Exclusion Criteria & Emergency Red Flags
- Active, uncontrolled bleeding or high risk of hemorrhage.
- Inability to provide informed consent per Federal Decree-Law No. 4 of 2016 on Medical Liability for minors or unconscious patients.
- Hemodynamic instability (systolic BP < 90 mmHg, acute shock).
ER Red Flags – seek immediate emergency care if you experience:
- Sudden severe headache, slurred speech, facial droop (possible intracranial hemorrhage).
- Chest pain, shortness of breath, or coughing up blood.
- Heavy or uncontrolled bleeding, black tarry stools, or blood in urine.
Patient FAQ & Clinical Guidance
1. What is the Heparin Anti‑Xa test used for?
This assay directly quantifies heparin's anticoagulant effect, guiding precise dosing to avoid thrombosis or hemorrhage. The test measures anti‑factor Xa activity, reflecting the inhibitory effect of the heparin‑antithrombin complex. It is critical for patients on unfractionated heparin to maintain therapeutic range and prevent recurrent clots or excessive bleeding.
2. How should I prepare for the test?
You must fast for 8 hours prior, avoid aspirin and non‑steroidal anti‑inflammatory drugs (NSAIDs), and inform us of all current medications. The Heparin Anti‑Xa test requires a platelet‑poor plasma sample collected under strict cold‑chain conditions. Our phlebotomist will handle the double‑centrifugation and immediate freezing. A completed Send Out Consent Form (Form 35) is mandatory before collection.
3. When will I receive my results?
Results are reported within 2 to 3 weeks after sample dispatch, with telephonic clinical interpretation available from our General Practitioner. The turnaround time depends on the send‑out logistics and the specialized reference laboratory's batch schedule. We provide a secure online portal and direct callback from a clinical consultant once the result is verified.
UAE Regulatory & Data Privacy Adherence
Trust & Compliance Framework
This service adheres to the Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) for the processing of your health information. All clinical data is handled in strict compliance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Our facility is licensed by the Dubai Health Authority (License No. 1143) and operates under the corporate governance of DNA Labs UAE. We maintain rigorous internal policies to ensure your data remains confidential, secure, and used solely for your diagnostic benefit.
Clinical & Logistical Metadata
| Test Name | Heparin Anti‑Xa Assay (Unfractionated Heparin) |
| Price (AED) | 2,500 AED |
| Turnaround Time | 2–3 Weeks (Send‑Out to Reference Laboratory) |
| Sample Type / Matrix | Platelet‑Poor Plasma (Double Centrifugation, Cold Chain) |
| Methodology Used | Chromogenic Anti‑Xa Assay (CLSI H47‑A2 Compliant) |
| ICD-10-CM Code | Z51.81 (Encounter for Therapeutic Drug Monitoring) |
| LOINC Code | 63082-8 (Heparin Anti‑Xa in Platelet‑Poor Plasma by Chromogenic Method) |
| DHA Facility License & Address | Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians